Jeantet advises Turenne Santé in connection with its acquisition of a minority stake in H.A.C.Pharma to support the company’s development and strengthen its product portfolio
Paris, February 2, 2022– Jeantet advised Turenne Santé in connection with its acquisition of a minority stake in the pharmaceutical company H.A.C. Pharma, via the FPCI (Fonds Professionnel de Capital Investissement, or Professional private equity investment fund) Capital Santé 2, as lead investor, and BNP Paribas Développement. This transaction marks a new stage in the […]
Paris | MERGERS & ACQUISITIONS (large & mid cap)